i3 2021 | 13-16 September
i3 is our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation!
Aspen Survey: Biopharma Development Data Management
In a recent survey of biopharma development teams, participants reported spending an average of 1 day each week, or 20% of their time on data administration.
Webinar | How to Harness the Full Potential of Biologics Data at High-Throughput
Managing bioprocess data is a complex challenge even if you run just a few experiments per month. With HTPD this can quickly scale up to hundreds of automated, parallelized experiments. Used effectively as part of a BioPharma Lifecycle Management strategy, the data generated from HTPD can accelerate development by supporting better decision making and reducing timelines.
Datasheet: Upstream Processing
IDBS Polar Bioprocess seamlessly integrates both process and analytical data throughout your workflows to deliver greater insight, enabling you to optimize upstream unit operations for maximum productivity.
Webinar | Digital Innovation to Support Quality by Design
In this webinar IDBS will share how an innovative approach to biopharma lifecycle management supports true QbD and can accelerate development to bring products to market faster.
Beating the Capacity Crunch: Rethinking the Biopharma Supply Chain to Avoid Shortages
One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.
6-8 July | Transforming Drug Discovery Through Artificial Intelligence Conference
Join Alberto Pascual, IDBS’s Director of Data Science and Analytics where he will discussing how you can join the digital transformation revolution by democratizing the use of advance analytics!
Adapting to the Challenge COVID-19 Presents to Create a New Biopharma Normal
In a recent Forbes article, Danaher’s Chief Science officer, Jose-Carlos Gutierrez-Ramos, described the impact of the COVID-19 pandemic as follows:“I believe the biopharma business model has fundamentally changed.
Sample Characterization with LabVoice
VideoHow many times a day do you walk across the lab to get to your ELN and record your data? Whatever the number, it’s still too many. It pulls you away from your bench, away from the science. It’s a…
The Importance of Compliance in R&D
eBookRegardless of the industry an organization operates in, remaining compliant with ever-changing legislation is an important aspect of corporate operations. For businesses that focus on research and development however, it’s essential. This is because of the frequently high-risk…
